Found: 43
Select item for more details and to access through your institution.
Beyond visual inspection: The value of infrared thermography in skin diseases, a scoping review.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 9, p. 1723, doi. 10.1111/jdv.19796
- By:
- Publication type:
- Article
721 - Efficacy and safety of povorcitinib for extensive vitiligo: 52-week results from a double-blinded, placebo-controlled, dose-ranging phase 2b study.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.094
- By:
- Publication type:
- Article
722 - Efficacy of povorcitinib for the treatment of vitiligo by patient demographics and baseline clinical characteristics: week 52 subgroup analysis from a randomized, placebo-controlled, phase 2b clinical trial.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.095
- By:
- Publication type:
- Article
Exploring the Severity Strata of Disease Activity and Repigmentation in Vitiligo Based on Validated Physician Global Assessment (PGA) Scores.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2680, doi. 10.3390/jcm13092680
- By:
- Publication type:
- Article
Patient-reported outcomes following 24 weeks of treatment with upadacitinib in adults with nonsegmental vitiligo: results from a phase 2, randomized, double-blind, dose-ranging study.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii64, doi. 10.1093/bjd/ljad498.065
- By:
- Publication type:
- Article
Efficacy and safety of upadacitinib in a phase 2 randomized, double-blind, dose-ranging study of adults with extensive non-segmental vitiligo.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii65, doi. 10.1093/bjd/ljad498.066
- By:
- Publication type:
- Article
Hot spots for clinical signs of disease activity in vitiligo.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 1, p. 1, doi. 10.1111/exd.14975
- By:
- Publication type:
- Article
A meta‐analysis of the placebo response in vitiligo: Causes and consequences for the interpretation of clinical trials.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 1, p. 74, doi. 10.1111/pcmr.13132
- By:
- Publication type:
- Article
The Impact of Antioxidants on Vitiligo and Melasma: A Scoping Review and Meta-Analysis.
- Published in:
- Antioxidants, 2023, v. 12, n. 12, p. 2082, doi. 10.3390/antiox12122082
- By:
- Publication type:
- Article
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. 2173, doi. 10.1111/jdv.19451
- By:
- Publication type:
- Article
Clinician‐reported outcome measures for the assessment of vitiligo: A scoping review.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. 2231, doi. 10.1111/jdv.19448
- By:
- Publication type:
- Article
The real‐life efficacy of methotrexate in vitiligo: A retrospective study and literature review.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. 2267, doi. 10.1111/jdv.19400
- By:
- Publication type:
- Article
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 8, p. 2289, doi. 10.1007/s00403-023-02611-8
- By:
- Publication type:
- Article
Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 10, p. 1124, doi. 10.1001/jamadermatol.2023.2787
- By:
- Publication type:
- Article
Initiating value‐based healthcare in psoriasis: Proposing a value‐based outcome set for daily clinical practice.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 3, p. 528, doi. 10.1111/jdv.18696
- By:
- Publication type:
- Article
Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 2, p. 247, doi. 10.1093/bjd/ljac074
- By:
- Publication type:
- Article
Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. 21, doi. 10.1111/jdv.18593
- By:
- Publication type:
- Article
Credibility and Generalization of the Minimally Important Difference Concept in Dermatology: A Scoping Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties.
- Published in:
- Pigment Cell & Melanoma Research, 2022, v. 35, n. 5, p. 480, doi. 10.1111/pcmr.13056
- By:
- Publication type:
- Article
From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.932265
- By:
- Publication type:
- Article
Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 7, p. 1167, doi. 10.3390/jpm12071167
- By:
- Publication type:
- Article
The delicate relation between melanocytes and skin immunity: A game of hide and seek.
- Published in:
- Pigment Cell & Melanoma Research, 2022, v. 35, n. 4, p. 392, doi. 10.1111/pcmr.13037
- By:
- Publication type:
- Article
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
- Published in:
- Drugs in R&D, 2021, v. 21, n. 3, p. 341, doi. 10.1007/s40268-021-00349-0
- By:
- Publication type:
- Article
Assessment of Non-cultured Autologous Epidermal Cell Grafting Resuspended in Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism Lesions: A Randomized Clinical Trial.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 7, p. 1, doi. 10.2340/00015555-3870
- By:
- Publication type:
- Article
Patients' Perception of Vitiligo Severity.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 6, p. 1, doi. 10.2340/00015555-3823
- By:
- Publication type:
- Article
Autoimmunity in Segmental Vitiligo.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.568447
- By:
- Publication type:
- Article
Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 5, p. 728, doi. 10.1111/pcmr.12784
- By:
- Publication type:
- Article
Learning From Success and Failure: Biologics for Non-approved Skin Diseases.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01918
- By:
- Publication type:
- Article
Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08337-4
- By:
- Publication type:
- Article
Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 5, p. 625, doi. 10.1007/s40257-018-0366-5
- By:
- Publication type:
- Article
Occupational allergic contact dermatitis caused by thebaine and oripavine.
- Published in:
- Contact Dermatitis (01051873), 2017, v. 76, n. 2, p. 120, doi. 10.1111/cod.12654
- By:
- Publication type:
- Article
Clinical Significance of Serum Soluble CD Molecules to Assess Disease Activity in Vitiligo.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A short dermoscopy training increases diagnostic performance in both inexperienced and experienced dermatologists.
- Published in:
- Australasian Journal of Dermatology, 2015, v. 56, n. 1, p. 52, doi. 10.1111/ajd.12203
- By:
- Publication type:
- Article
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-014-0376-x
- By:
- Publication type:
- Article
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 403, doi. 10.1186/s12967-014-0376-x
- By:
- Publication type:
- Article
Hypomelanoses in Children.
- Published in:
- Journal of Cutaneous & Aesthetic Surgery, 2013, v. 6, n. 2, p. 65, doi. 10.4103/0974-2077.112665
- By:
- Publication type:
- Article
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
- Published in:
- Nature Genetics, 2012, v. 44, n. 6, p. 676, doi. 10.1038/ng.2272
- By:
- Publication type:
- Article
In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial.
- Published in:
- Pigment Cell & Melanoma Research, 2012, v. 25, n. 1, p. 57, doi. 10.1111/j.1755-148X.2011.00922.x
- By:
- Publication type:
- Article
Koebner's phenomenon in vitiligo: European position paper.
- Published in:
- Pigment Cell & Melanoma Research, 2011, v. 24, n. 3, p. 564, doi. 10.1111/j.1755-148X.2011.00838.x
- By:
- Publication type:
- Article
Comprehensive Association Analysis of Candidate Genes for Generalized Vitiligo Supports XBP1, FOXP3, and TSLP.
- Published in:
- Journal of Investigative Dermatology, 2011, v. 131, n. 2, p. 371, doi. 10.1038/jid.2010.337
- By:
- Publication type:
- Article
A Review of Non-cultured Epidermal Cellular Grafting in Vitiligo.
- Published in:
- Journal of Cutaneous & Aesthetic Surgery, 2011, v. 4, n. 1, p. 17, doi. 10.4103/0974-2077.79181
- By:
- Publication type:
- Article
First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
- Published in:
- Pigment Cell & Melanoma Research, 2010, v. 23, n. 3, p. 375, doi. 10.1111/j.1755-148X.2010.00703.x
- By:
- Publication type:
- Article